J.-S. Chen

404 total citations
12 papers, 161 citations indexed

About

J.-S. Chen is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, J.-S. Chen has authored 12 papers receiving a total of 161 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 5 papers in Pulmonary and Respiratory Medicine and 4 papers in Surgery. Recurrent topics in J.-S. Chen's work include Gastric Cancer Management and Outcomes (3 papers), Colorectal Cancer Treatments and Studies (2 papers) and Pancreatic and Hepatic Oncology Research (2 papers). J.-S. Chen is often cited by papers focused on Gastric Cancer Management and Outcomes (3 papers), Colorectal Cancer Treatments and Studies (2 papers) and Pancreatic and Hepatic Oncology Research (2 papers). J.-S. Chen collaborates with scholars based in Taiwan, South Korea and United States. J.-S. Chen's co-authors include Yen‐Ni Hung, Siew Tzuh Tang, Huang‐Chih Chang, Chuang‐Chi Liaw, H S Leu, Kuang‐Hui Yu, Yi‐Hao Lin, Lai‐Chu See, Wen‐Kuan Huang and Yuan‐Tso Cheng and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Oncology and Alimentary Pharmacology & Therapeutics.

In The Last Decade

J.-S. Chen

12 papers receiving 160 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J.-S. Chen Taiwan 6 95 65 54 21 18 12 161
Eline Naert Belgium 7 77 0.8× 115 1.8× 41 0.8× 20 1.0× 17 0.9× 21 224
Wenwu Cheng China 11 158 1.7× 82 1.3× 36 0.7× 17 0.8× 35 1.9× 24 310
Elizabeth Shuster United States 10 57 0.6× 38 0.6× 30 0.6× 30 1.4× 20 1.1× 23 236
Roula Ajrouche Lebanon 8 88 0.9× 48 0.7× 91 1.7× 20 1.0× 7 0.4× 20 248
Alessandra Malossi Italy 5 52 0.5× 97 1.5× 24 0.4× 17 0.8× 36 2.0× 7 185
Matthew Howse United Kingdom 7 79 0.8× 12 0.2× 40 0.7× 28 1.3× 19 1.1× 18 313
Bishnu Dutta Paudel Nepal 8 52 0.5× 38 0.6× 19 0.4× 11 0.5× 21 1.2× 34 169
Paige D. Wartko United States 8 63 0.7× 42 0.6× 52 1.0× 8 0.4× 47 2.6× 20 241
Katherine Faricy‐Anderson United States 9 249 2.6× 131 2.0× 137 2.5× 15 0.7× 12 0.7× 22 338
Roberto Bernáldez-Rı́os Mexico 9 128 1.3× 43 0.7× 118 2.2× 27 1.3× 8 0.4× 16 224

Countries citing papers authored by J.-S. Chen

Since Specialization
Citations

This map shows the geographic impact of J.-S. Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J.-S. Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J.-S. Chen more than expected).

Fields of papers citing papers by J.-S. Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J.-S. Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J.-S. Chen. The network helps show where J.-S. Chen may publish in the future.

Co-authorship network of co-authors of J.-S. Chen

This figure shows the co-authorship network connecting the top 25 collaborators of J.-S. Chen. A scholar is included among the top collaborators of J.-S. Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J.-S. Chen. J.-S. Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Yen, Chia‐Jui, M-H. Chen, J.-S. Chen, et al.. (2024). 1145MO CVM-005: Phase IIa study of CVM-1118, a novel oral anti-vasculogenic mimicry (VM) agent, in advanced neuroendocrine tumors (NET) after progression on prior therapy. Annals of Oncology. 35. S751–S751. 1 indexed citations
2.
Chou, Wen‐Chi, et al.. (2018). Incidence, risk factors, and outcomes of arterial thromboembolism in patients with pancreatic cancer following palliative chemotherapy. Annals of Oncology. 29. ix63–ix63. 1 indexed citations
3.
4.
5.
Satoh, Taroh, L.-T. Chen, Yoon‐Koo Kang, et al.. (2018). A phase III study of nivolumab (nivo) in previously treated advanced gastric or gastric esophageal junction (G/GEJ) cancer (ATTRACTION-2): Two-years update data. Annals of Oncology. 29. viii206–viii206. 9 indexed citations
6.
7.
Huang, Wen‐Kuan, M.-J. Chiou, Kuang‐Hui Yu, et al.. (2013). The association between low-dose aspirin use and the incidence of colorectal cancer: a nationwide cohort study. Alimentary Pharmacology & Therapeutics. 38(4). 432–439. 16 indexed citations
8.
Tang, Siew Tzuh, et al.. (2008). Trends in quality of end-of-life care for Taiwanese cancer patients who died in 2000–2006. Annals of Oncology. 20(2). 343–348. 97 indexed citations
9.
Chang, Huang‐Chih, et al.. (2006). A Phase II Randomized Study of Two Taxanes and Cisplatin for Metastatic Breast Cancer after Anthracycline: A Final Analysis. Japanese Journal of Clinical Oncology. 37(1). 23–29. 15 indexed citations
10.
Chen, J.-S., et al.. (2004). Phase I dosing-escalating study of oxaliplatin in combination with oral tegafur-uracil/leucorvin in patients with advanced gastric cancer. Journal of Clinical Oncology. 22(14_suppl). 4266–4266. 1 indexed citations
11.
Chen, J.-S., et al.. (2004). Phase I dosing-escalating study of oxaliplatin in combination with oral tegafur-uracil/leucorvin in patients with advanced gastric cancer. Journal of Clinical Oncology. 22(14_suppl). 4266–4266. 1 indexed citations
12.
Cheng, Yuan‐Tso, et al.. (1997). Central nervous system infection due toClostridium septicum: A case report and review of the literature. Infection. 25(3). 171–174. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Eline Naert Breakdown of academic impact, for papers by Wenwu Cheng Breakdown of academic impact, for papers by Elizabeth Shuster Breakdown of academic impact, for papers by Roula Ajrouche Breakdown of academic impact, for papers by Alessandra Malossi Breakdown of academic impact, for papers by Matthew Howse Breakdown of academic impact, for papers by Bishnu Dutta Paudel Breakdown of academic impact, for papers by Paige D. Wartko Breakdown of academic impact, for papers by Katherine Faricy‐Anderson Breakdown of academic impact, for papers by Roberto Bernáldez-Rı́os
Rankless by CCL
2026